Ph.D., Chief Business Development and Analytics Officer, Cancer Treatment Centers of America (CTCA)
Biography
Rob’s responsibilities include identifying business opportunities to leverage a growing longitudinal clinical-genomic database for use in multiple healthcare channels. Prior to joining CTCA, Rob held 2 roles at ASCO including Senior Director of External Relations and Business Development for CancerLinQ and Senior Director of Quality Department and directed a large staff responsible for development of oncology quality measures, ASCO Guidelines, QOPI, QOPI Certification Program, and the development of the CancerLinQ program. In his 25 year career, Rob has led over 30 research activities, built businesses from idea to sale, and accumulated significant experience in business development, health economic and strategy planning services, clinical trial development, oncology registries, EMR systems, and informatics. He has served in roles as VP of Operations and Informatics while at International Oncology Network, and six years as VP and COO at Geriatric Oncology Consortium. He also spent two years with the research/consulting firm Abt Associates.
Session Abstract – PMWC 2020 Silicon Valley
Track 4 - January 22 2.00 P.M.-3.00 P.M.
The purpose of clinical decision support tools and systems is to provide accurate, timely information to the clinical team and patient to help inform about a patient’s care. Clinical decision support can potentially lower costs, improve patient outcomes and efficiency, and reduce patient inconvenience. In this session, we will hear from representatives from major healthcare organizations about their perspectives and experiences when adopting/implementing clinical decision support.
